BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 19036674)

  • 1. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.
    Kamal SM; Graham CS; He Q; Bianchi L; Tawil AA; Rasenack JW; Khalifa KA; Massoud MM; Koziel MJ
    J Infect Dis; 2004 Apr; 189(7):1140-50. PubMed ID: 15031780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.
    Sturm N; Thélu MA; Camous X; Dimitrov G; Ramzan M; Dufeu-Duchesne T; Bonorino P; Guillermet C; Brambilla E; Arvers P; Pernollet M; Leroy V; Zarski JP; Marche PN; Jouvin-Marche E
    J Hepatol; 2010 Jul; 53(1):25-35. PubMed ID: 20452085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
    Kamar N; Rostaing L; Sandres-Saune K; Selves J; Barthe C; Dubois M; Alric L; Durand D; Izopet J
    J Med Virol; 2005 Aug; 76(4):482-8. PubMed ID: 15977245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.
    Miroux C; Vausselin T; Delhem N
    Expert Opin Biol Ther; 2010 Nov; 10(11):1563-72. PubMed ID: 20932226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C.
    Ferri S; Lalanne C; Lanzoni G; Bassi M; Asioli S; Cipriano V; Pappas G; Muratori P; Lenzi M; Muratori L
    Dig Liver Dis; 2011 Oct; 43(10):807-13. PubMed ID: 21684822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
    Tseng CT; Miskovsky E; Houghton M; Klimpel GR
    Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.
    Bonilla N; Barget N; Andrieu M; Roulot D; Letoumelin P; Grando V; Trinchet JC; Ganne-Carrié N; Beaugrand M; Deny P; Choppin J; Guillet J; Ziol M
    J Viral Hepat; 2006 Jul; 13(7):474-81. PubMed ID: 16792541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.
    Castello G; Scala S; Palmieri G; Curley SA; Izzo F
    Clin Immunol; 2010 Mar; 134(3):237-50. PubMed ID: 19910258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
    Claassen MA; de Knegt RJ; Tilanus HW; Janssen HL; Boonstra A
    J Hepatol; 2010 Mar; 52(3):315-21. PubMed ID: 20129690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
    Ward SM; Fox BC; Brown PJ; Worthington J; Fox SB; Chapman RW; Fleming KA; Banham AH; Klenerman P
    J Hepatol; 2007 Sep; 47(3):316-24. PubMed ID: 17475362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
    Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.